Free Alerts   Login

Great Point Partners 13F filings

Manager(s): Dr. Jeffrey Jay, M.D. and Mr. David Kroin

Holdings as of 2024-06-30

Filed on 2024-08-14 under CIK 1281446

Company
Investment Type
Change
Value (x$1000)
increase or decrease
UroGen Pharma Ltd. COM
2,906,259 sh
285,714 sh
11%
$48,767
$9,459
NEUROGENE INC COM
1,004,291 sh
 
$36,546
Abivax SA F Sponsored ADR Stock
2,472,188 sh
-16,295 sh
-1%
$32,682
-$2,903
MERUS N V COM
523,288 sh
300,000 sh
134%
$30,963
$20,908
Pliant Therapeutics Inc. COM
2,636,864 sh
785,000 sh
42%
$28,346
$753
ARCELLX INC
492,000 sh
192,000 sh
64%
$27,153
$6,288
Dynavax Technologies Corp
2,374,000 sh
1,109,080 sh
88%
$26,660
$10,962
EVOLUS INC COM
2,451,772 sh
1,772 sh
0%
$26,602
-$7,698
CYTOKINETICS INC COM NEW
474,202 sh
272,000 sh
135%
$25,692
$11,516
DIANTHUS THERAPEUTICS INC COM
757,929 sh
132,929 sh
21%
$19,615
$865
INSMED INC COM PAR $.01
250,000 sh
-525,585 sh
-68%
$16,750
-$4,292
ZURA BIO LTD CLASS A ORD SHS
4,642,241 sh
1,884,501 sh
68%
$16,248
$9,161
KALVISTA PHARMACEUTICALS INC COM
1,338,568 sh
1,338,568 sh
NEW
$15,768
$15,768
Ionis Pharmaceuticals Inc
330,000 sh
330,000 sh
NEW
$15,728
$15,728
CONTEXT THERAPEUTICS INC COM COM
7,419,355 sh
7,419,355 sh
NEW
$14,876
$14,876
Amicus Therapeutics Inc
1,495,500 sh
 
$14,835
Optinose Inc
13,727,097 sh
4,940,779 sh
56%
$14,276
$1,448
Esperion Therapeutics Inc COM
5,791,594 sh
-2,208,406 sh
-28%
$12,857
-$8,583
Voyager Therapeutics Inc COM
1,601,527 sh
1,601,527 sh
NEW
$12,668
$12,668
OUTLOOK THERAPEUTICS INC COM Common Stock
1,701,510 sh
221,510 sh
15%
$12,557
-$5,114
AUTOLUS THERAPEUTICS PLC SPON ADS
3,441,667 sh
2,275,000 sh
195%
$11,977
$4,534
JASPER THERAPEURITC, INC. Stock
402,015 sh
-5,535 sh
-1%
$9,126
-$2,840
Olema Pharmaceuticals Inc. COM
796,880 sh
796,880 sh
NEW
$8,622
$8,622
Terns Pharmaceuticals Inc. COM
1,149,406 sh
-160,569 sh
-12%
$7,827
-$766
VIRIDIAN THERAPEUTICS Common Stock
500,000 sh
-835,000 sh
-63%
$6,505
-$16,871
TScan Therapeutics Inc.
940,831 sh
940,831 sh
NEW
$5,504
$5,504
VISTAGEN THERAPEUTICS ORD COM
1,529,338 sh
-329,397 sh
-18%
$5,322
-$4,492
HELIX ACQUISITION CORP II CL A ORD SHS
500,000 sh
 
$5,110
PUMA BIOTECHNOLOGY INC COM
1,486,544 sh
142,916 sh
11%
$4,846
-$2,275
Kyverna Therapeutics, Inc. Common Stock
499,152 sh
349,152 sh
233%
$3,744
$18
AEGLEA BIOTHERAPEUTICS INC cs
134,612 sh
9,612 sh
8%
$3,165
-$1,576
AnaptysBio Inc.
25,000 sh
-951,981 sh
-97%
$627
-$21,375
Lexicon Pharmaceuticals Inc COM NEW
30,000 sh
30,000 sh
NEW
$50
$50
ALPINE IMMUNE SCIENCES INC COM
0 sh
-1,128,499 sh
-100%
$0
-$44,734
APOGEE THERAPEUTICS INC COM
0 sh
-400,000 sh
-100%
$0
-$26,580
Aerovate Therapeutics Inc. COM
0 sh
-887,690 sh
-100%
$0
-$26,249
XENON PHARMACEUTICALS INC COM
0 sh
-456,148 sh
-100%
$0
-$19,637
MIND MEDICINE MINDMED INC COM NEW Stock
0 sh
-2,000,000 sh
-100%
$0
-$18,800
Ocular Therapeutix Inc
0 sh
-1,728,723 sh
-100%
$0
-$15,731
INTRA CELLULAR THERAPIES INC COM
0 sh
-150,000 sh
-100%
$0
-$10,380
IMMUNOCORE HOLDINGS PLC-ADR (IMCR US) ADS
0 sh
-115,000 sh
-100%
$0
-$7,475
Arvinas Inc COM
0 sh
-71,113 sh
-100%
$0
-$2,936